Liom Non-invasive Continuous Glucose Monitor "Clinical Demo" (niCGM)

StatusUnknown
PhaseNot applicable
Started

Record status This record was last updated October 1, 2024 (before its estimated July 21, 2025 completion). Its status may not reflect the trial's current state.

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Changed Registry marked status Unknown (sponsor has not verified the record since Sep 2024); last known: Recruiting
  2. Enrollment target: 40 to 80v3 Show 5 more changesShow less
    • Primary completion date: Nov 30, 2024 to Jul 21, 2025
    • Study completion date: Dec 31, 2024 to Jul 31, 2025
    • Study description revised
    • Study title revised
    • Eligibility criteria shortened, about 4 words
  3. Trial status: Not Yet Recruiting to Recruiting
    • Study sites: 0 to 1
    • Start date changed from estimate of Feb 12, 2024 to Feb 23, 2024
    v2
  4. Study First Submitted
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Liom Health AG
1 trial monitored
See all monitored trials
Diabetes
5,101 trials monitored
See 233 trials at risk
Type 2 Diabetes
2,236 trials monitored
See 113 trials at risk
Type 1 Diabetes
888 trials monitored
See 39 trials at risk
This is a single-centre, multiple cohort, open study.
Trial Details
NCT Number NCT06272136
Lead Sponsor Liom Health AG
Collaborators: Profil Institut für Stoffwechselforschung GmbH
Conditions
(from sponsor)		 Type 1 Diabetes, Type2diabetes
Related terms Diabetes Mellitus, Diabetes Mellitus, Type 1, Hyperglycemia
Enrollment 80 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov